License Issue Fees. GEN-PROBE paid to PHRI on signing of the Original License a license issue fee of $125,000. GEN-PROBE shall pay to PHRI on signing of this Agreement an amendment issue fee of $75,000.
License Issue Fees. Upon execution of this Agreement, and as a condition precedent to this Agreement, Licensee shall pay Demeter the following three amounts: (a) seven hundred thousand Dollars ($700,000) for the rights to Licensed Patents and Demeter Technology for use in Licensed Plant Products in the Field of Activity; (b) two hundred thousand Dollars ($200,000) for the rights to Demeter Patents and Demeter Technology for use in Formulated Licensed Products; and (c) an additional fifty thousand Dollars ($50,000) for a right of first refusal through October 1, 1998 to obtain an exclusive license to Demeter Nutrition Patents and Technology for applications involving nutrition in plants in accordance with the provisions of Article VI. (The information marked by *** has been omitted by a request for confidential treatment. The omitted portions will be separately filed with the Commission.)
License Issue Fees. Upon execution of this Agreement, Licensee shall be obligated to pay Licensor the sum of Five Hundred Thousand Dollars ($500,000), in partial consideration for the rights granted to Licensee under this Agreement. Such payment may be made, at the election of Licensee, either (a) in cash on the date of this Agreement, or (b) in fully paid and nonassessable shares of such equity security of Licensee as are issued in the next Qualified Financing (as defined below), at the price paid by the investors in such Qualified Financing and issued on the closing date of such Qualified Financing. If payment is made pursuant to Section ** REPRESENTS MATERIAL WHICH HAS BEEN REDACTED AND SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
License Issue Fees. Upon execution of this Agreement, Licensee will pay Licensor the sum of **, in exchange for the rights granted to Licensee under this Agreement.
License Issue Fees. GEN-PROBE paid to PHRI on signing of the Original License a license issue fee of [***]. GEN-PROBE shall pay to PHRI on signing of this Agreement an amendment issue fee of [***].
License Issue Fees. In consideration of full payment for the obligations of the previous set of three license agreements, which shall be replaced by this AGREEMENT, LICENSEE shall pay to LICENSOR ***. Such consideration is already deemed earned and immediately payable. CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. OMITTED INFORMATION IS INDICATED BY AN ASTERIK MARKING (***) AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
License Issue Fees. Upon execution of this Agreement, Licensee will pay Licensor the sum of Fifty Thousand Dollars ($50,000), in exchange for the rights granted to Licensee under this Agreement.
License Issue Fees. Company shall pay Hospital a non-refundable license issue fee in the amount of one hundred and [***] upon execution of this Agreement, and an additional deferred non-refundable license issue fee in the amount of [***] payable on the [***] of the Effective Date.
License Issue Fees. Upon execution of this Agreement, Licensee shall be obligated to pay Licensor the sum of **, in partial consideration for the rights granted to Licensee under this Agreement. Such payment may be made, at the election of Licensee, either (a) in cash on the date of this Agreement, or (b) in fully paid and nonassessable shares of such equity security of Licensee as are issued in the next Qualified Financing (as defined below), at the price paid by the investors in such Qualified Financing and issued on the closing date of such Qualified Financing. If payment is made pursuant to Section ** REPRESENTS MATERIAL WHICH HAS BEEN REDACTED AND SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
License Issue Fees. On or before the date thirty days after the Effective Date, and as consideration, in part, for the grant of the Licenses hereunder and the delivery of the Licensed Information pursuant to SECTION 3.1, TILLOTTS must pay to CPP a non-refundable, non-creditable license issue fee of Eight Million U.S. Dollars (US$8,000,000) (the “Issue Fee”) in respect of the rights granted hereunder in the countries of the Licensed Territory.
